A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

April 30, 2015

Conditions
Idiopathic Growth Hormone Deficiency
Interventions
PROCEDURE

Blood sampling

Blood sample will be collected at a single visit

Trial Locations (7)

Unknown

Szent János Kórház és Észak Budai Egyesített Kórházai (there may be other sites in this country), Budapest

Seth GSMC & KEM Hospital (there may be other sites in this country), Maharashtra

The Chaim Sheba Medical Center (there may be other sites in this country), Ramat Gan

Uniwersyteckie Centrum Kliniczne (there may be other sites in this country), Gdansk

Paediatric Endocrinology/Medicali's SRL (there may be other sites in this country), Timișoara

"Federal State Institution Endocrinology Scientific Center of Rosmedtechnology (there may be other sites in this country)", Moscow

Institute of Endocrinology and Metabolism named after Komisarenko of AMS Ukraine (there may be other sites in this country), Kiev

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT02173821 - A Follow-up Study to Examine the Presence of Anti-human Growth Hormone Antibodies Following a Study (FE 999905 CS07) of Zomacton in Children With Growth Hormone Deficiency | Biotech Hunter | Biotech Hunter